Dr. Douglas Dieterich: “The Beginning of the End for HCV in HIV: Or the End of the Beginning”
Douglas Dieterich, MD, discusses the application of data on current and emerging therapeutic regimens to improve treatment decision-making for patients with HIV/HCV coinfection. This activity is intended for gastroenterologists, hepatologists, infectious disease specialists, nurse practitioners, physician assistants, and other health care professionals involved in the treatment of patients with HCV. Learn more

Researchers Identify Potential Target for Treatment Among Patients With Type 2 Diabetes
Aug 04, 2022 View All Press Releases
Mount Sinai Researcher Receives Prestigious International Award
Jul 06, 2022 View All Press Releases